
Judith F. Baumhauer, MD, MPH
Associate Chair of Academic Affairs and Professor, Department of Orthopaedics, University of Rochester; Director, Clinical BioInformatics Core UR Health Care System
Welcome
What Health Care Consumers Will Need from Health Care
Roundtable Discussion
Realizing Equitable Access and Quality of Care
OptumRx Executive Q&A (Sponsor Session)
Integrating the Patient Voice: Patient-Reported Outcomes
Associate Chair of Academic Affairs and Professor, Department of Orthopaedics, University of Rochester; Director, Clinical BioInformatics Core UR Health Care System
Chief Experience Officer of the Cleveland Clinic Health System and Staff Neurologist at the Cleveland Clinic Mellen Center for Multiple Sclerosis
James F. Fries Professor of Medicine; Bloomberg Distinguished Professor, Johns Hopkins University School of Medicine, School of Nursing, and
Bloomberg School of Public Health; Director, Johns Hopkins Center for Health Equity; Director, Johns Hopkins Urban Health Institute
Chief Executive Officer and President
RoMed
Chief Medical Officer
OptumRx
Editor-in-Chief, NEJM Catalyst Innovations in Care Delivery; Co-Chair, NEJM Catalyst Editorial Board; Chief Medical Officer, Press Ganey Associates, Inc.
Member, Editorial Board, New England Journal of Medicine
Executive Editor, NEJM Catalyst Innovations in Care Delivery; Physician, Brigham Health; Associate Faculty, Ariadne Labs; Assistant Professor, Harvard Medical School
Editorial Director
NEJM Catalyst
Health Assurance Acquisition Corp.; Former President and Chief Medical Officer, Livongo
Dr. Baumhauer serves as Associate Chair of Academic Affairs and Professor, Department of Orthopaedics at the University of Rochester. In addition to providing clinical care, she holds the position as the Director of the Clinical BioInformatics Core for the UR Health Care System and is a board of director of Accountable Health Partners, ACO for the Rochester Region.
She received her bachelor’s degree from Springfield College, master’s degree in Biology from Middlebury College, and Doctorate of Medicine from the University of Vermont College of Medicine. She completed orthopaedic residency at the Medical Center Hospital of Vermont and a Fellowship in Foot and Ankle Surgery at the Medical College of Wisconsin. While working as an Attending at the University of Rochester, she obtained a Master in Public Health degree from the University of Rochester Department of Community and Preventive Medicine.
Dr. Baumhauer is the past President of the American Board of Orthopaedic Surgery, American Orthopaedic Foot and Ankle Society (AOFAS), and Eastern Orthopaedic Association. Dr. Baumhauer currently is the President-Elect of the PROMIS Health Organization. Dr. Baumhauer has published over 200 peer-reviewed papers and book chapters. Her research interest focuses on the use of patient reported outcomes (PROs) in clinical decision-making to improve the care provided to patients. Additionally, she has studied how PROs affect patient engagement, patient satisfaction, and clinical efficiency. Dr. Baumhauer is a Board of Trustee for the American Journal of Bone and Joint Surgery and a reviewer for Clinical Orthopaedics and Related Research, Foot and Ankle International, American Journal of Bone and Joint Surgery, and the Journal of Orthopaedic Research.
Adrienne Boissy, MD, MA, is the Chief Experience Officer of the Cleveland Clinic Health System and a staff neurologist at the Cleveland Clinic Mellen Center for Multiple Sclerosis. Dr. Boissy leads initiatives to address and improve every aspect of a patient’s encounter with the Cleveland Clinic Health System — from their physical comfort to their educational, emotional, and spiritual needs. Based on what matters most to patients, she sets the enterprise strategic vision for how to enable human-centered care through design thinking, digital engagement, and compassionate innovation.
Dr. Boissy co-chairs the Empathy and Innovation summit, the largest independent summit on patient experience in the world. She serves as Editor Emeritus of the Journal of Patient Experience, on the Editorial Board of NEJM Catalyst, and serves on the Advisory Board for Option B. She has published extensively about transformational change needed in patient centered measurement, relational communication, burnout, and empathy, and advocates for major operational changes in health care systems for a more humane experience, noted in her provocative TED talk “Can empathy help heal health care?” Her work has been featured in The Wall Street Journal, NPR, The Washington Post, Forbes, and The Atlantic, among others. A Harvard Macy scholar, she has been repeatedly recognized as a leading physician executive and thought leader.
Lisa A. Cooper is a general internist, social epidemiologist, and health services researcher. She studies how racism and socioeconomic factors shape patient care and health outcomes, how patients can become more activated in improving their health, and how health systems can partner with communities to help populations with complex medical and social needs achieve health equity.
Dr. Cooper founded and currently directs The Johns Hopkins Center for Health Equity, where she and her transdisciplinary team implement clinical trials, identifying interventions that alleviate racial and income disparities in social determinants and health outcomes and translating these interventions into practice and policy changes and community health benefits. The Center has developed an active and engaged community advisory board, trained over 100 health equity researchers, and shared influential new knowledge through published research papers, expert testimony at federal level, and numerous presentations, interviews, and media articles. Dr. Cooper currently leads projects in the United States and sub-Saharan Africa that investigate whether system improvements and team-based care models can help reduce disparities in cardiovascular risk factors including hypertension, diabetes, and depression.
She is a 2007 MacArthur Fellow and an elected member of the National Academy of Medicine.
Dr Jens Deerberg-Wittram, MD, is the Chief Executive Officer and President of RoMed, a nonprofit health system of four hospitals and 15 outpatient centers serving a region of 400,000 people in South Germany.
He is the founding President of the International Consortium for Health Outcomes Measurement (ICHOM), a nonprofit institute cofounded by Professor Michael Porter at Harvard Business School, The Karolinska Institutet, and Boston Consulting Group in order to unlock the potential of value-based health care by defining global Standard Sets of outcome measures and driving adoption and reporting of these measures worldwide.
Before joining ICHOM in 2012, he served from 2002 to 2012 as the CEO of a German for-profit hospital group of 15 hospitals and 4,800 beds.
Dr Deerberg has worked as a strategy consultant at the Boston Consulting for over 10 years serving leading health care provider, payer, and supplier organizations. He finished a management trainee program at a global med tech company.
Dr Deerberg served in various health care associations, e.g., as a board member of the German Private Hospitals’ Association and the OECD High Level Expert Group on health statistics. He is a member of the Newsweek World’s Best Hospitals Board of Experts.
Dr Deerberg has been a Senior Fellow and Faculty Member of the Harvard Business School and he is regular lecturer on value-based health care at the Universities of Hamburg and Paris Dr Deerberg received his medical degree from the University Kiel and he holds a doctorate in Molecular Oncology.
As Chief Medical Officer at OptumRx – a national pharmacy care services company serving 59 million Americans – Dr. Dutta leads all clinical programs focused on achieving better health outcomes for patients, lowering costs for the health care system, and improving the health care experience for consumers. Dr. Dutta has a team of 5,000 pharmacists and pharmacy technicians that help patients every day learn how to take their medications, avoid harmful drug interactions and manage their chronic conditions.
Dr. Dutta brings over three decades of experience in health care. He has been with UnitedHealth Group since 2015 and joined OptumRx as part of the Catamaran acquisition. Before joining Catamaran, Dr. Dutta led Quest Diagnostics’ India subsidiary, driving growth in the diagnostics, employer and clinical trials laboratory testing markets. Dr. Dutta previously served in various senior executive roles at the pharmacy benefits manager, Medco, including President of Accredo NovaFactor and chief medical officer of Medco’s health plans division.
Dr. Dutta is one of several leaders overseeing OptumRx’s Inclusion & Diversity(I&D) initiative, which advocates for inclusive practices within Optum’s workforce as well as encourages the creation of programs that advance inclusion, diversity and health equity in the communities OptumRx serves.
Dr. Dutta earned his medical degree from Michigan State University and a Master of Business Administration from New York University, Stern School of Business. He completed his internship at the University of Chicago Hospitals and Clinics and residency at Rush Medical Center, practicing Internal Medicine at New York University Health Center.
Dr. Thomas Lee is Chief Medical Officer of Press Ganey, and an internist and cardiologist who practices at Brigham and Women’s Hospital in Boston. He is a Professor of Medicine, part time, at Harvard Medical School and Professor of Health Policy and Management at the Harvard School of Public Health. Prior to joining Press Ganey, he served as Network President for Partners Healthcare System and Chief Executive Officer for Partners Community HealthCare, Inc., the integrated delivery system founded by Brigham and Women’s Hospital and Massachusetts General Hospital.
He is a member of the Board of Directors of Geisinger Health System, Chairman of the Board of Directors for the Geisinger Health Plan, Geisinger Quality Options, Inc., and Geisinger Indemnity Insurance Company Board of Directors. He is also a member of the Board of Directors of Health Leads; the Board of Overseers of Weill Cornell Medical College; the Special Medical Advisory Group (SMAG) of the Veterans Administration; and the Panel of Health Advisors of the Congressional Budget Office. He is a member of the Editorial Board of the New England Journal of Medicine, as well as Editor-in-Chief of NEJM Catalyst Innovations in Care Delivery and Co-Chair of the NEJM Catalyst Editorial Board.
He is the author of more than 260 academic articles and three books, Chaos and Organization in Health Care, Eugene Braunwald and the Rise of Modern Medicine, and An Epidemic of Empathy in HealthcarNamed in his honor, the Thomas H. Lee Award for Excellence in Primary Care is given each year to recognize a primary care physician at Brigham and Women’s Hospital who meets the needs of his or her patients exceptionally well.
Tom holds a bachelor’s degree in History and Science from Harvard College, a medical degree from Cornell University Medical College, and a master’s degree in Epidemiology from the Harvard School of Public Health. He lives in Milton, Massachusetts, with his wife, Dr. Soheyla Gharib, who is Chief of Medicine at Harvard University Health Services. The couple has three daughters.
Namita Seth Mohta, MD, is a physician executive with expertise in health care delivery transformation. As the Executive Editor for NEJM Catalyst; Innovations in Care Delivery, she is part of the founding leadership team and has responsibility for content strategy and quality. Most recently, Dr. Mohta served as the Director, Serious Illness Care Program (SICP), at Ariadne Labs, a health system innovation center at the Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health. SICP is focused on the design, test, and spread of solutions to improve care for patients and caregivers experiencing serious illness. Dr Mohta has been part of the founding Population Health and ACO leadership teams as Medical Director, both at Partners HealthCare (now MassGeneral Brigham) and the New England Quality Care Alliance (Tufts Medical Center), both in Boston. Her responsibilities have included designing and implementing value-based care with a focus on scaling tailored clinical interventions, integrating analytics and measurement, and leading system-wide change management efforts. Dr Mohta has worked with multiple start-ups, including PatientPing (now Bamboo Health), a digital health company, as their Physician Lead, with a focus on building products that improve care. She often consults with organizations to provide strategic and technical expertise and leadership. She worked as a management consultant with the Boston Consulting Group prior to medical training.
Dr. Mohta practices internal medicine as a hospitalist at the Brigham and Women’s Hospital and is Assistant Professor in the Department of Medicine at Harvard Medical School. Dr. Mohta is former faculty at the Center for Healthcare Delivery Sciences and current associate faculty at Ariadne Labs. She completed her Internal Medicine and Primary Care residency training at the Brigham and Women’s Hospital. Dr. Mohta is a graduate of Yale College and Yale School of Medicine.
As Editorial Director for NEJM Catalyst, Edward Prewitt oversees all editorial content for the monthly journal, NEJM Catalyst Innovations in Care Delivery; monthly Insights reports; and quarterly events. He works closely with NEJM Catalyst advisors, authors, and colleagues to ensure that editorial content advances the national and international dialogue to drive innovation in health care delivery, while upholding NEJM Group’s high standards for quality.
Dr. Jennifer Schneider joined the Board of the Health Assurance Acquisition Corp., a Special Purpose Acquisition Company (SPAC) with Hemant Taneja, Glen Tullman, Dr. Stephen Klasko, Quentin Clark, and Anita V. Pramoda in October 2020. Their mission is to partner with leading health and care businesses leveraging technology to support their efforts to become iconic category winners that accelerate the digital transformation of existing healthcare into a new system of health assurance.
Prior to joining the Board of Health Assurance Acquisition Corp., Jennifer served as the Chief Medical Officer and President of Livongo for 5 years. At Livongo, I was responsible for product, data science, engineering, marketing, clinical operations, and our growth strategy. In her final year at Livongo, she helped lead the company through the largest consumer digital health Initial Public Offering in history, a secondary offering, a convertible debt offering that raised over $540 million, and the industry’s largest merger ever between Livongo and Teladoc Health, valuing Livongo at $18.5 billion and beginning a new era of consumer centric virtual care.
Jennifer was honored by Modern Healthcare as one of the 50 Most Influential Clinical Executives and by Fierce Healthcare as Woman of Influence for our work empowering women and modeling diversity and inclusion in the workplace.